Long-term, heavy ketamine use is associated with memory problems, depression and anxiety. The drug may also cause ...

Gilgamesh managed to overcome the issue of functional unblinding in the study, an obstacle experienced by the psychedelic ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a generative AI-based system for speeding up drug review - and plans to roll out ...

They’re mainly used to reduce the appearance of wrinkles. Daxxify is newer than Botox, with the FDA approving it in 2022. Botox has been approved since 2002. Daxxify and Botox both contain the ...